1TYLDESLEY S, BOYD C, SCHULZE K, et al. Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach [ J ]. lnt J Radiat Oncol Biol Phys, 2001, 49 (4) : 973-985.
2SCOTT W J, HOWINGTON J, FEIGENBERG S, et al. Treatment of non-small cell lung cancer stage Ⅰ and stage Ⅱ : ACCP Evidence-Based Clinical Practice Guidelines ( 2nd Edition ) [ J ]. Chest, 2007,132(3 ) :234S-242S.
3GOYA T, ASAMURA H, YOSHIMURA H,et al. Prognosis of 6 644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study [ J ]. Lung Cancer, 2005 , 50 ( 2 ) : 227- 234.
4ONISHI H, SHIRATO H, NAGATA Y, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage 1 non-smaU cell lung cancer: updated results of 257 patients in a Japanese multiinstitutional study[J]. J Thorac Oncol,2007,2( Suppl 3) : S94- S100
5TIMMERMAN RD, PAPIEZ L, MC GARRY R,et al. Extracranial stereotactic radioablation : results of a phase Ⅰ study in medically inoperable stage Ⅰ non-small cell lung cancer[ J ]. Chest ,2003, 124 : 1946-1955.
6UEMATSU M, SHIODA A, SUDA A, et al. Computed tomographyguided frameless stereotactic radiotherapy for stage 1 nonsmall cell lung cancer: a 5-year experience[ J].Int J Radiat Oncol Biol Phys,2001,51 (3) :666-670.
7XIA T, LI H, SUN Q,et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage Ⅰ/Ⅱ non-small-cell lung cancer [ J ]. Int J Radiat Oncol Biol Phys, 2006 ,66( 1 ) : 117-125 .
8TIMMERMAN R, MCGARRY R, YIANNOUTSOS C,et al. Excessive toxicity when treating central tumors in a phase Ⅱ study of stereotactic body radiation therapy for medically inoperable earlystage lung cancer[J]. J Clin Oncol,2006 ,24(30) :4833-4839.
9Hoff DR, Ryan GJ, Driver ER,et al. Location of intra and extracellular m. tuberculosis populations in lungs of mice and guinea pigs during disease progression and after drug treat ment[J]. PLos One,2011,6(3):17550-17559.
10Ohashi R,Kato M,Katsura Y,etal. Breakthrough lung sce dosporium prolificans infection with multiple cavity lesions in a patient receiving voriconazole for probable invasive aspergil losis associated with monoclonal gammopathy of undeter mined significance (MGUS) [J ]. Nippon Ishinkin Gakkai Zasshi,2011,52(1) :33-38.
